Resource Library

Resource Library

Filter Resources

Area of Interest

Resource Type

      Poster

      Immunoscore® analytical performance

      Poster

      LTX-315, a first in class oncolytic peptide reshapes the tumor microenvironment inducing a local and systemic effect in metastatic tumors: Results from an ongoing study

      Poster

      Prognostic utility of immune markers and validation of Immunoscore® in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial

      Poster

      A multiplex immunohistochemistry assay for immune cells profiling on whole FFPE tumor tissue sections

      Poster

      Immunoscore IC (previously Halioseek® PD‐L1/CD8), a dual CD8 and PD‐L1 IVD assay to improve NSCLC patients stratification

      Poster

      LTX-315, a first in class oncolytic peptide, reshapes the tumor microenvironment in the patients with advanced metastatic tumors: Results from an ongoing study

      Poster

      Immunoscore provides prognostic information in low (T3N1) and high (T4 or N2) risk subsets of stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial [NCCTG N0147 (Alliance)

      Poster

      Multi-centric PD-L1 and CD8 IHC assessment in NSCLC using IMMUNOSCORE® IC previously Halioseek®) CE-IVD assay

      Poster

      A Phase I/II study of the oncolytic peptide LTX-315 combined with checkpoint inhibition generates de novo T-cell responses and clinical benefit in patients with advanced solid tumors

      Poster

      T cell exhaustion assessment using an automated sequential chromogenic multiplex assay (Brightplex®)

    Contact our team to discuss your project